Gilead Sciences Secures Exclusive Option to Acquire Pionyr ImmunotherapeuticsBusiness Wire • 06/23/20
Gilead Analyst Questions Remdesivir's Ultimate Upside As Study Begins For Inhaled VersionBenzinga • 06/22/20
Gilead Unveils New Wave Of Coronavirus Tests, Including Inhaled DrugInvestors Business Daily • 06/22/20
Vaccines Will Underwhelm, And Why Gilead Has A Substantially Larger Market OpportunitySeeking Alpha • 06/20/20